ALLR Stock Summary and Trading Ideas (Allarity Therapeutics | NASDAQ:ALLR)

Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States. It is focused on the clinical development of its lead program: Stenoparib, which is being co-developed with a drug specific DRP companion diagnostic.

What symbol and exchange does Allarity Therapeutics shares trade?

Allarity Therapeutics trades on the NASDAQ stock market under the symbol ALLR.

What is Allarity Therapeutics stock price doing today?

As of July 16, 2026, ALLR stock price declined to $1.17 with 92,245 million shares trading.

What is Allarity Therapeutics's Beta?

ALLR has a beta of 1.01, meaning it tends to be more sensitive to market movements. ALLR has a correlation of 0.02 to the broad based SPY ETF.

How much is Allarity Therapeutics worth?

ALLR has a market cap of $18.62 million. This is considered a Sub-Micro Cap stock.

What is the highest and lowest price Allarity Therapeutics traded in the last 3 year period?

In the last 3 years, ALLR traded as high as $2,070.00 and as low as $.61.

What are the top ETFs holding Allarity Therapeutics?

The top ETF exchange traded funds that ALLR belongs to (by Net Assets): VXF.

Is Allarity Therapeutics (ALLR) a good investment?

ALLR has underperformed the market in the last year with a price return of +15.8% while the SPY ETF gained +21.9%. ALLR has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -6.4% and -12.0%, respectively, while the SPY returned +7.5% and +0.7%, respectively.

What are the support and resistance levels for Allarity Therapeutics (ALLR)?

ALLR support price is $1.12 and resistance is $1.25 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ALLR shares will trade within this expected range on the day.